0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Oral Tranexamic Acid Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-5V16841
Home | Market Reports | Health| Pharmacy
Global Oral Tranexamic Acid Market Research Report 2024
BUY CHAPTERS

Global Oral Tranexamic Acid Market Research Report 2025

Code: QYRE-Auto-5V16841
Report
September 2025
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Oral Tranexamic Acid Market

The global market for Oral Tranexamic Acid was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Oral Tranexamic Acid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oral Tranexamic Acid.
The Oral Tranexamic Acid market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Oral Tranexamic Acid market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Oral Tranexamic Acid manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Oral Tranexamic Acid Market Report

Report Metric Details
Report Name Oral Tranexamic Acid Market
Segment by Type
  • Tablets
  • Capsules
Segment by Application
  • Acute Bleeding
  • Chronic Bleeding
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Daiichi Sankyo, Teva Pharmaceuticals, Hunan Dongting Pharmaceutical, CR Double-Crane, Shanghai Sine Pharmaceutical, Sinopharm Group, China Resources Sanjiu
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Oral Tranexamic Acid manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Oral Tranexamic Acid in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Oral Tranexamic Acid Market report?

Ans: The main players in the Oral Tranexamic Acid Market are Daiichi Sankyo, Teva Pharmaceuticals, Hunan Dongting Pharmaceutical, CR Double-Crane, Shanghai Sine Pharmaceutical, Sinopharm Group, China Resources Sanjiu

What are the Application segmentation covered in the Oral Tranexamic Acid Market report?

Ans: The Applications covered in the Oral Tranexamic Acid Market report are Acute Bleeding, Chronic Bleeding, Others

What are the Type segmentation covered in the Oral Tranexamic Acid Market report?

Ans: The Types covered in the Oral Tranexamic Acid Market report are Tablets, Capsules

1 Oral Tranexamic Acid Market Overview
1.1 Product Definition
1.2 Oral Tranexamic Acid by Type
1.2.1 Global Oral Tranexamic Acid Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablets
1.2.3 Capsules
1.3 Oral Tranexamic Acid by Application
1.3.1 Global Oral Tranexamic Acid Market Value by Application (2024 VS 2031)
1.3.2 Acute Bleeding
1.3.3 Chronic Bleeding
1.3.4 Others
1.4 Global Oral Tranexamic Acid Market Size Estimates and Forecasts
1.4.1 Global Oral Tranexamic Acid Revenue 2020-2031
1.4.2 Global Oral Tranexamic Acid Sales 2020-2031
1.4.3 Global Oral Tranexamic Acid Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Oral Tranexamic Acid Market Competition by Manufacturers
2.1 Global Oral Tranexamic Acid Sales Market Share by Manufacturers (2020-2025)
2.2 Global Oral Tranexamic Acid Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Oral Tranexamic Acid Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Oral Tranexamic Acid, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Oral Tranexamic Acid, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Oral Tranexamic Acid, Product Type & Application
2.7 Global Key Manufacturers of Oral Tranexamic Acid, Date of Enter into This Industry
2.8 Global Oral Tranexamic Acid Market Competitive Situation and Trends
2.8.1 Global Oral Tranexamic Acid Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Oral Tranexamic Acid Players Market Share by Revenue
2.8.3 Global Oral Tranexamic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Oral Tranexamic Acid Market Scenario by Region
3.1 Global Oral Tranexamic Acid Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Oral Tranexamic Acid Sales by Region: 2020-2031
3.2.1 Global Oral Tranexamic Acid Sales by Region: 2020-2025
3.2.2 Global Oral Tranexamic Acid Sales by Region: 2026-2031
3.3 Global Oral Tranexamic Acid Revenue by Region: 2020-2031
3.3.1 Global Oral Tranexamic Acid Revenue by Region: 2020-2025
3.3.2 Global Oral Tranexamic Acid Revenue by Region: 2026-2031
3.4 North America Oral Tranexamic Acid Market Facts & Figures by Country
3.4.1 North America Oral Tranexamic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Oral Tranexamic Acid Sales by Country (2020-2031)
3.4.3 North America Oral Tranexamic Acid Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Oral Tranexamic Acid Market Facts & Figures by Country
3.5.1 Europe Oral Tranexamic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Oral Tranexamic Acid Sales by Country (2020-2031)
3.5.3 Europe Oral Tranexamic Acid Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Oral Tranexamic Acid Market Facts & Figures by Region
3.6.1 Asia Pacific Oral Tranexamic Acid Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Oral Tranexamic Acid Sales by Region (2020-2031)
3.6.3 Asia Pacific Oral Tranexamic Acid Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Oral Tranexamic Acid Market Facts & Figures by Country
3.7.1 Latin America Oral Tranexamic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Oral Tranexamic Acid Sales by Country (2020-2031)
3.7.3 Latin America Oral Tranexamic Acid Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Oral Tranexamic Acid Market Facts & Figures by Country
3.8.1 Middle East and Africa Oral Tranexamic Acid Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Oral Tranexamic Acid Sales by Country (2020-2031)
3.8.3 Middle East and Africa Oral Tranexamic Acid Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Oral Tranexamic Acid Sales by Type (2020-2031)
4.1.1 Global Oral Tranexamic Acid Sales by Type (2020-2025)
4.1.2 Global Oral Tranexamic Acid Sales by Type (2026-2031)
4.1.3 Global Oral Tranexamic Acid Sales Market Share by Type (2020-2031)
4.2 Global Oral Tranexamic Acid Revenue by Type (2020-2031)
4.2.1 Global Oral Tranexamic Acid Revenue by Type (2020-2025)
4.2.2 Global Oral Tranexamic Acid Revenue by Type (2026-2031)
4.2.3 Global Oral Tranexamic Acid Revenue Market Share by Type (2020-2031)
4.3 Global Oral Tranexamic Acid Price by Type (2020-2031)
5 Segment by Application
5.1 Global Oral Tranexamic Acid Sales by Application (2020-2031)
5.1.1 Global Oral Tranexamic Acid Sales by Application (2020-2025)
5.1.2 Global Oral Tranexamic Acid Sales by Application (2026-2031)
5.1.3 Global Oral Tranexamic Acid Sales Market Share by Application (2020-2031)
5.2 Global Oral Tranexamic Acid Revenue by Application (2020-2031)
5.2.1 Global Oral Tranexamic Acid Revenue by Application (2020-2025)
5.2.2 Global Oral Tranexamic Acid Revenue by Application (2026-2031)
5.2.3 Global Oral Tranexamic Acid Revenue Market Share by Application (2020-2031)
5.3 Global Oral Tranexamic Acid Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Daiichi Sankyo
6.1.1 Daiichi Sankyo Company Information
6.1.2 Daiichi Sankyo Description and Business Overview
6.1.3 Daiichi Sankyo Oral Tranexamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Daiichi Sankyo Oral Tranexamic Acid Product Portfolio
6.1.5 Daiichi Sankyo Recent Developments/Updates
6.2 Teva Pharmaceuticals
6.2.1 Teva Pharmaceuticals Company Information
6.2.2 Teva Pharmaceuticals Description and Business Overview
6.2.3 Teva Pharmaceuticals Oral Tranexamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Teva Pharmaceuticals Oral Tranexamic Acid Product Portfolio
6.2.5 Teva Pharmaceuticals Recent Developments/Updates
6.3 Hunan Dongting Pharmaceutical
6.3.1 Hunan Dongting Pharmaceutical Company Information
6.3.2 Hunan Dongting Pharmaceutical Description and Business Overview
6.3.3 Hunan Dongting Pharmaceutical Oral Tranexamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Hunan Dongting Pharmaceutical Oral Tranexamic Acid Product Portfolio
6.3.5 Hunan Dongting Pharmaceutical Recent Developments/Updates
6.4 CR Double-Crane
6.4.1 CR Double-Crane Company Information
6.4.2 CR Double-Crane Description and Business Overview
6.4.3 CR Double-Crane Oral Tranexamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.4.4 CR Double-Crane Oral Tranexamic Acid Product Portfolio
6.4.5 CR Double-Crane Recent Developments/Updates
6.5 Shanghai Sine Pharmaceutical
6.5.1 Shanghai Sine Pharmaceutical Company Information
6.5.2 Shanghai Sine Pharmaceutical Description and Business Overview
6.5.3 Shanghai Sine Pharmaceutical Oral Tranexamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Shanghai Sine Pharmaceutical Oral Tranexamic Acid Product Portfolio
6.5.5 Shanghai Sine Pharmaceutical Recent Developments/Updates
6.6 Sinopharm Group
6.6.1 Sinopharm Group Company Information
6.6.2 Sinopharm Group Description and Business Overview
6.6.3 Sinopharm Group Oral Tranexamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sinopharm Group Oral Tranexamic Acid Product Portfolio
6.6.5 Sinopharm Group Recent Developments/Updates
6.7 China Resources Sanjiu
6.7.1 China Resources Sanjiu Company Information
6.7.2 China Resources Sanjiu Description and Business Overview
6.7.3 China Resources Sanjiu Oral Tranexamic Acid Sales, Revenue and Gross Margin (2020-2025)
6.7.4 China Resources Sanjiu Oral Tranexamic Acid Product Portfolio
6.7.5 China Resources Sanjiu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Oral Tranexamic Acid Industry Chain Analysis
7.2 Oral Tranexamic Acid Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Oral Tranexamic Acid Production Mode & Process Analysis
7.4 Oral Tranexamic Acid Sales and Marketing
7.4.1 Oral Tranexamic Acid Sales Channels
7.4.2 Oral Tranexamic Acid Distributors
7.5 Oral Tranexamic Acid Customer Analysis
8 Oral Tranexamic Acid Market Dynamics
8.1 Oral Tranexamic Acid Industry Trends
8.2 Oral Tranexamic Acid Market Drivers
8.3 Oral Tranexamic Acid Market Challenges
8.4 Oral Tranexamic Acid Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Oral Tranexamic Acid Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Oral Tranexamic Acid Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Oral Tranexamic Acid Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Oral Tranexamic Acid Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Oral Tranexamic Acid Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Oral Tranexamic Acid Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Oral Tranexamic Acid Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Oral Tranexamic Acid Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Oral Tranexamic Acid, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Oral Tranexamic Acid, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Oral Tranexamic Acid, Product Type & Application
 Table 12. Global Key Manufacturers of Oral Tranexamic Acid, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Oral Tranexamic Acid by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Tranexamic Acid as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Oral Tranexamic Acid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Oral Tranexamic Acid Sales by Region (2020-2025) & (K Units)
 Table 18. Global Oral Tranexamic Acid Sales Market Share by Region (2020-2025)
 Table 19. Global Oral Tranexamic Acid Sales by Region (2026-2031) & (K Units)
 Table 20. Global Oral Tranexamic Acid Sales Market Share by Region (2026-2031)
 Table 21. Global Oral Tranexamic Acid Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Oral Tranexamic Acid Revenue Market Share by Region (2020-2025)
 Table 23. Global Oral Tranexamic Acid Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Oral Tranexamic Acid Revenue Market Share by Region (2026-2031)
 Table 25. North America Oral Tranexamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Oral Tranexamic Acid Sales by Country (2020-2025) & (K Units)
 Table 27. North America Oral Tranexamic Acid Sales by Country (2026-2031) & (K Units)
 Table 28. North America Oral Tranexamic Acid Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Oral Tranexamic Acid Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Oral Tranexamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Oral Tranexamic Acid Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Oral Tranexamic Acid Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Oral Tranexamic Acid Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Oral Tranexamic Acid Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Oral Tranexamic Acid Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Oral Tranexamic Acid Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Oral Tranexamic Acid Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Oral Tranexamic Acid Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Oral Tranexamic Acid Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Oral Tranexamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Oral Tranexamic Acid Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Oral Tranexamic Acid Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Oral Tranexamic Acid Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Oral Tranexamic Acid Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Oral Tranexamic Acid Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Oral Tranexamic Acid Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Oral Tranexamic Acid Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Oral Tranexamic Acid Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Oral Tranexamic Acid Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Oral Tranexamic Acid Sales (K Units) by Type (2020-2025)
 Table 51. Global Oral Tranexamic Acid Sales (K Units) by Type (2026-2031)
 Table 52. Global Oral Tranexamic Acid Sales Market Share by Type (2020-2025)
 Table 53. Global Oral Tranexamic Acid Sales Market Share by Type (2026-2031)
 Table 54. Global Oral Tranexamic Acid Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Oral Tranexamic Acid Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Oral Tranexamic Acid Revenue Market Share by Type (2020-2025)
 Table 57. Global Oral Tranexamic Acid Revenue Market Share by Type (2026-2031)
 Table 58. Global Oral Tranexamic Acid Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Oral Tranexamic Acid Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Oral Tranexamic Acid Sales (K Units) by Application (2020-2025)
 Table 61. Global Oral Tranexamic Acid Sales (K Units) by Application (2026-2031)
 Table 62. Global Oral Tranexamic Acid Sales Market Share by Application (2020-2025)
 Table 63. Global Oral Tranexamic Acid Sales Market Share by Application (2026-2031)
 Table 64. Global Oral Tranexamic Acid Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Oral Tranexamic Acid Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Oral Tranexamic Acid Revenue Market Share by Application (2020-2025)
 Table 67. Global Oral Tranexamic Acid Revenue Market Share by Application (2026-2031)
 Table 68. Global Oral Tranexamic Acid Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Oral Tranexamic Acid Price (US$/Unit) by Application (2026-2031)
 Table 70. Daiichi Sankyo Company Information
 Table 71. Daiichi Sankyo Description and Business Overview
 Table 72. Daiichi Sankyo Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Daiichi Sankyo Oral Tranexamic Acid Product
 Table 74. Daiichi Sankyo Recent Developments/Updates
 Table 75. Teva Pharmaceuticals Company Information
 Table 76. Teva Pharmaceuticals Description and Business Overview
 Table 77. Teva Pharmaceuticals Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Teva Pharmaceuticals Oral Tranexamic Acid Product
 Table 79. Teva Pharmaceuticals Recent Developments/Updates
 Table 80. Hunan Dongting Pharmaceutical Company Information
 Table 81. Hunan Dongting Pharmaceutical Description and Business Overview
 Table 82. Hunan Dongting Pharmaceutical Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Hunan Dongting Pharmaceutical Oral Tranexamic Acid Product
 Table 84. Hunan Dongting Pharmaceutical Recent Developments/Updates
 Table 85. CR Double-Crane Company Information
 Table 86. CR Double-Crane Description and Business Overview
 Table 87. CR Double-Crane Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. CR Double-Crane Oral Tranexamic Acid Product
 Table 89. CR Double-Crane Recent Developments/Updates
 Table 90. Shanghai Sine Pharmaceutical Company Information
 Table 91. Shanghai Sine Pharmaceutical Description and Business Overview
 Table 92. Shanghai Sine Pharmaceutical Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Shanghai Sine Pharmaceutical Oral Tranexamic Acid Product
 Table 94. Shanghai Sine Pharmaceutical Recent Developments/Updates
 Table 95. Sinopharm Group Company Information
 Table 96. Sinopharm Group Description and Business Overview
 Table 97. Sinopharm Group Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Sinopharm Group Oral Tranexamic Acid Product
 Table 99. Sinopharm Group Recent Developments/Updates
 Table 100. China Resources Sanjiu Company Information
 Table 101. China Resources Sanjiu Description and Business Overview
 Table 102. China Resources Sanjiu Oral Tranexamic Acid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. China Resources Sanjiu Oral Tranexamic Acid Product
 Table 104. China Resources Sanjiu Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Oral Tranexamic Acid Distributors List
 Table 108. Oral Tranexamic Acid Customers List
 Table 109. Oral Tranexamic Acid Market Trends
 Table 110. Oral Tranexamic Acid Market Drivers
 Table 111. Oral Tranexamic Acid Market Challenges
 Table 112. Oral Tranexamic Acid Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Oral Tranexamic Acid
 Figure 2. Global Oral Tranexamic Acid Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Oral Tranexamic Acid Market Share by Type: 2024 & 2031
 Figure 4. Tablets Product Picture
 Figure 5. Capsules Product Picture
 Figure 6. Global Oral Tranexamic Acid Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Oral Tranexamic Acid Market Share by Application: 2024 & 2031
 Figure 8. Acute Bleeding
 Figure 9. Chronic Bleeding
 Figure 10. Others
 Figure 11. Global Oral Tranexamic Acid Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Oral Tranexamic Acid Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Oral Tranexamic Acid Sales (2020-2031) & (K Units)
 Figure 14. Global Oral Tranexamic Acid Average Price (US$/Unit) & (2020-2031)
 Figure 15. Oral Tranexamic Acid Report Years Considered
 Figure 16. Oral Tranexamic Acid Sales Share by Manufacturers in 2024
 Figure 17. Global Oral Tranexamic Acid Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Oral Tranexamic Acid Players: Market Share by Revenue in Oral Tranexamic Acid in 2024
 Figure 19. Oral Tranexamic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Oral Tranexamic Acid Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Oral Tranexamic Acid Sales Market Share by Country (2020-2031)
 Figure 22. North America Oral Tranexamic Acid Revenue Market Share by Country (2020-2031)
 Figure 23. United States Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Oral Tranexamic Acid Sales Market Share by Country (2020-2031)
 Figure 26. Europe Oral Tranexamic Acid Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Oral Tranexamic Acid Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Oral Tranexamic Acid Revenue Market Share by Region (2020-2031)
 Figure 34. China Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Southeast Asia Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Latin America Oral Tranexamic Acid Sales Market Share by Country (2020-2031)
 Figure 42. Latin America Oral Tranexamic Acid Revenue Market Share by Country (2020-2031)
 Figure 43. Mexico Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Brazil Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Argentina Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Middle East and Africa Oral Tranexamic Acid Sales Market Share by Country (2020-2031)
 Figure 47. Middle East and Africa Oral Tranexamic Acid Revenue Market Share by Country (2020-2031)
 Figure 48. Turkey Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. UAE Oral Tranexamic Acid Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Global Sales Market Share of Oral Tranexamic Acid by Type (2020-2031)
 Figure 52. Global Revenue Market Share of Oral Tranexamic Acid by Type (2020-2031)
 Figure 53. Global Oral Tranexamic Acid Price (US$/Unit) by Type (2020-2031)
 Figure 54. Global Sales Market Share of Oral Tranexamic Acid by Application (2020-2031)
 Figure 55. Global Revenue Market Share of Oral Tranexamic Acid by Application (2020-2031)
 Figure 56. Global Oral Tranexamic Acid Price (US$/Unit) by Application (2020-2031)
 Figure 57. Oral Tranexamic Acid Value Chain
 Figure 58. Channels of Distribution (Direct Vs Distribution)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart